Public COA audit

Double Agonist · Tirzepatide

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
93%
Panels
3/7
Purity (printed)
99.9%

Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), and 2 soft concerns. To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
PR-TRZ10-B1-0626-1
Identity method
HPLC-RTM
Sample date
2026-07-06
Issue date
2026-07-24

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.90%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    All Not Detected

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity

    99.90% purity by HPLC is excellent and typical for research-grade peptides. Clean chromatogram with single dominant peak.

  • Identity confirmed

    Tirzepatide identity confirmed by HPLC-RTM method.

  • Fentanyl screening included

    Immunoassay fentanyl screen performed with 50 ng/mL cutoff, not detected. This is a valuable safety test.

  • Heavy metals panel complete

    ICP-MS testing for As, Cd, Pb, Hg, Cr all passed (not detected).

  • Verification URL provided

    QR code and verification URL (portal.ils-lab.com/verify/...) present for independent verification.

  • Batch information complete

    Lot number PR-TRZ10-B1-0626-1, accession ACC-2026-8267, labeled content 10mg.

  • Dates consistent

    Date received 2026-07-06, analysis date 2026-07-24, issued 2026-07-24. All dates are logical and sequential.

  • Endotoxin panel not present

    This report does not include endotoxin testing. For injectable peptides, endotoxin testing is typically recommended. This may be a purity/identity-scoped report; endotoxin may have been tested separately.

  • Microbial and sterility panels absent

    No microbial contamination or sterility testing shown on this report. These may be tested separately or not required for this product type.

  • Professional presentation

    Document is well-formatted with clear tables, chromatogram, lab accreditation logos (ISO/IEC 17025, FDA GMP), and signature of Lab Director Dr. Greg Kalyuzhny.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.